No abstract

Out of 1170 patients with macrohaematuria treated at the Clinic of Urology, "Pirogov" Institute, Sofia, 592 had profuse haematuria. With reference to the volume of blood loss the criteria for haematuria to be designated profuse are discussed. The most frequent diseases which led to profuse haematuria, as well as the methods for the etiological diagnosis of haematuria are reviewed. The authors present the experience they obtained from conservative and operative treatment of the syndrome, and stress that preference is given to the methods aiming at radical sanation of the basic disease.

The treatment of urinary incontinence represents an important medico-social problem, notwithstanding the offered 90 products of treatment. The authors summarice their experience on the treatment of urinary incontinence with clenbuterol for the period 1988-1997. During this period total of 335 patients (163 women and 72 men), aged between 30 and 73 were treated. The medicine was used in the treatment of women with stress incontinence (60) and urge incontinence (103). In cases of combination between urinary incontinence and hyperreflexy of the detrusor, and antiholynergic therapy was used. It was used after surgery of the adenoma of the prostate in men, aged 62-73: in 50 of them after transvesical prostatectomy, and in 22 after transurethral resection of the prostate. The authors determine the period of using the product in the different kinds of incontinence. Clenbuterol can be effective only when sfincter activity is preserved, which is proved by means of urodynamic tests. The durability of treatment was stable in 86% of treated women, and in 76.3% of treated men. The authors determine the indications and contraindications of administration of celbuterol. They analise the changes in the hydrodynamic of the lower urinary tract in the patients with urinary incontinence after clenbuterol therapy.

The role of Streptococcus agalactiae (group B streptococci, GBS) was investigated for a period of one year in different clinical forms of urinary tract infection in males and non-pregnant females over 14 years of age. The pathogen has been isolated in quantities of greater than or equal to 10(5) cfu/ml in midstream voided urine from 32 patients with clinical signs of urinary tract infection and pathologic urinary sediment. In every group of B isolates the antibiotic sensitivity to antimicrobial agents was determined by the single disk method of Kirby-Bauer. GBS with the same characteristics were established in urethral specimens of 4 males as well as in the vagina and faeces of 11 females. As a rule, peroral treatment with ampicillin proceeded successfully. In addition, women with streptococcal vaginitis were treated topically with 2% solution of chlorhexidine. Our results have demonstrated that GBS might cause urinary tract infection, but the evaluation of GBS isolated in urine specimens is complex.

Triptorelin pamoate 11.25 mg given in microgranules is a 3-month sustained-release administration form which appears to be safe and effective in advanced prostatic carcinoma. Based on the findings of this study, the formulation with greater bioavailability (DLGSD-3-95-21) was selected as formulation of choice to be used for clinical treatments and further clinical investigation.

No abstract